Market Forecasts and Industry Analysis Medical Foods Market Analysis By Route Of Administ | Page 2
The prevalence of chronic diseases such as diabetic neuropathy, Alzheimer's, Attention Deficit
Hyperactivity Disorder (ADHD), and several metabolic diseases is increasing rapidly The risk of
neuropathy significantly increases with increase in age, changes in diet, and adoption of an unhealthy
lifestyle. Some of the symptoms usually associated with neuropathy include numbness, tingling, and
pain in the feet, arms, & legs. Furthermore, some of the key products used to treat this condition
include Percura capsules, METANX, and Foltanx.
Complete Report Available @ https://www.radiantinsights.com/research/medical-
foods-market
The growing number of patients with Alzheimer's disease is also increasing rapidly. As per the
estimates published by the Alzheimer's Society, in the U.S., an estimated 5.4 million Americans
across all ages are suffering from this disease. On further analysis of the data, it is observed that
nearly 5.2 million people are aged 65 and above. Thus, rise in the geriatric population is also a major
factor driving the medical foods market.
Further Key Findings From the Study Suggest:
In 2015, oral route held the highest share as majority of the products are administered through
the oral feeding
In 2015, powders category accounted for nearly 79% of the market share
In 2015, diabetic neuropathy was the largest application with a share of 34.3% owing to
growing awareness about nutritional requirements during the treatment of chronic diseases
Asia Pacific is expected to lead the growth with a CAGR of 7.8% from 2016 to 2025
See More Reports of This Category by Radiant Insights @
https://www.radiantinsights.com/catalog/chemicals-and-materials
Follow Us: